Segall Bryant & Hamill’s Diebold Nixdorf DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
MCM
VCM
BPCM
Segall Bryant & Hamill's DBD Position: Q1 2026 in Review
Segall Bryant & Hamill reduced its Diebold Nixdorf (DBD) stake by 2.9% in Q1 2026, selling an estimated $82.3K and leaving 36,890 shares worth $2.78M. The position accounts for 0.04% of the portfolio, ranked #379.
Segall Bryant & Hamill first reported a position in DBD in Q2 2025 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.
- Segall Bryant & Hamill held 36,890 shares of Diebold Nixdorf worth $2.78M as of Q1 2026.
- Segall Bryant & Hamill sold 1,119 Diebold Nixdorf shares in Q1 2026, an estimated $82.3K.
- Diebold Nixdorf made up 0.04% of Segall Bryant & Hamill's portfolio in Q1 2026, its #379 holding.
- Segall Bryant & Hamill first reported a position in Diebold Nixdorf in Q2 2025 and has held it in 4 quarters since.
- 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.
Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.